Local Tech Wire

RESEARCH TRIANGLE PARK, N.C. – Get the latest news alerts: Proventys, a startup focused on personalized medicine that was founded by former Duke University Chancellor Ralph Snyderman, has closed on another $3.25 million in financing.

The company, which is based in Massachusetts, wants to raise $5.1 million, according to a filing with the SEC.

Proventys raised $5.65 million in 2008.

Synderman launched Proventys in 2004. He remains the firm’s chairman.

Timothy Thompson, a former director of mergers and acquisitions at Aetna, is its chief executive officer.

In 2006, Proventys closed on $1 million in funding.

The company describes itself as a “company at the forefront of transforming health care into a personalized and preventative approach through the development of unique risk assessment and clinical decision support tools. These tools should rapidly become part of the patients’ clinical evaluation to improve their care and therapy as a result of evidence-based decisions and personalization.”

Burrill & Company, an internationally known life science investment firm, is an investor.

Get the latest news alerts: Follow LTW at Twitter.